SAB Biotherapeutics to trade on Nasdaq following merger
Sioux Falls-based SAB Biotherapeutics plans to merge with a Miami-based firm, which will allow it to trade on the Nasdaq.
Sioux Falls-based SAB Biotherapeutics plans to merge with a Miami-based firm, which will allow it to trade on the Nasdaq.